UNIVERSITY OF UTAH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1850-02-28
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.utah.edu
Comparative Effectiveness of Acute Low Back Pain Management
Not Applicable
Completed
- Conditions
- Low Back Pain
- Interventions
- Other: Usual CareOther: Early Physical Therapy with Usual Care
- First Posted Date
- 2012-11-15
- Last Posted Date
- 2018-10-09
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 220
- Registration Number
- NCT01726803
- Locations
- 🇺🇸
The University of Utah Healthcare System, Salt Lake City, Utah, United States
🇺🇸Intermountain Health Care, Salt Lake City, Utah, United States
Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage
Phase 4
Completed
- Conditions
- Atrial Fibrillation
- Interventions
- Drug: Optison echocardiography contrast agent
- First Posted Date
- 2012-11-04
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 100
- Registration Number
- NCT01721447
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Hemostatic Effects of VELCADE®* Treatment in Multiple Myeloma Patients
Phase 2
Terminated
- Conditions
- Multiple Myeloma
- Interventions
- Drug: Velcade
- First Posted Date
- 2012-11-01
- Last Posted Date
- 2017-09-05
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 8
- Registration Number
- NCT01720043
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients
Phase 2
Completed
- Conditions
- Atrial FibrillationCoronary Artery Disease
- Interventions
- Drug: Regadenoson MRIDrug: Gadobenate dimeglumine
- First Posted Date
- 2012-10-19
- Last Posted Date
- 2017-12-13
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 30
- Registration Number
- NCT01710254
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia
Phase 2
Completed
- Conditions
- Severe Aplastic AnemiaVery Severe Aplastic AnemiaModerate Aplastic Anemia
- Interventions
- First Posted Date
- 2012-10-10
- Last Posted Date
- 2017-10-19
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 13
- Registration Number
- NCT01703169
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Gulf War 1 Veteran Healthcare Satisfaction
Withdrawn
- Conditions
- Persian Gulf War Syndrome in Veteran
- Interventions
- Behavioral: Provider Education Workshop
- First Posted Date
- 2012-10-10
- Last Posted Date
- 2016-08-11
- Lead Sponsor
- University of Utah
- Registration Number
- NCT01703767
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
🇺🇸VA SLC Health Care System, Salt Lake City, Utah, United States
A Study of Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma
Phase 1
Completed
- Conditions
- Melanoma
- Interventions
- Drug: Intratumoral Ipilimumab and Interleukin-2
- First Posted Date
- 2012-08-24
- Last Posted Date
- 2015-07-08
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 12
- Registration Number
- NCT01672450
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Nutrient Regulation of Amino Acid Transporters in Aging Human Skeletal Muscle
Completed
- Conditions
- Healthy
- First Posted Date
- 2012-08-21
- Last Posted Date
- 2016-11-16
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 28
- Registration Number
- NCT01669590
- Locations
- 🇺🇸
The University of Utah, Salt Lake City, Utah, United States
Comparison of Electrotherapies for Chronic Low Back Pain
Not Applicable
Completed
- Conditions
- Non-specific Chronic Low Back Pain
- Interventions
- Device: ShamDevice: H-WaveDevice: Transcutaneous Electrical Nerve Stimulation (TENS)
- First Posted Date
- 2012-08-07
- Last Posted Date
- 2015-03-09
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 113
- Registration Number
- NCT01658735
Antiplatelet Activity of Aspirin in Infants After Aortopulmonary and Cavopulmonary Shunts
Completed
- Conditions
- Congenital Heart Disease
- First Posted Date
- 2012-08-03
- Last Posted Date
- 2017-05-05
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 25
- Registration Number
- NCT01656993
- Locations
- 🇺🇸
Primary Children's Medical Center, Salt Lake City, Utah, United States
© Copyright 2025. All Rights Reserved by MedPath